Heron Therapeutics (HRTX) Retained Earnings (2010 - 2026)
Heron Therapeutics (HRTX) reported Retained Earnings of -$6000.0 for Q1 2026, up 100.0% on a YoY basis from -$3000.0 in Q1 2025, and down 250.0% quarter-over-quarter from $4000.0 in Q4 2025.
Heron Therapeutics (HRTX) Retained Earnings (2010 - 2026) Analysis & Trends
Heron Therapeutics has reported Retained Earnings for 17 years, with the latest figure at -$6000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 100.0% year-over-year to -$6000.0; the trailing twelve-month figure through Mar 2026 stood at -$6000.0 (up 100.0% YoY), and the FY2025 full-year result was $4000.0, down 69.23% from the prior year.
- Retained Earnings for Q1 2026 stood at -$6000.0, down from $4000.0 in the prior quarter.
- The five-year high for Retained Earnings was $40000.0 in Q3 2024, with the low at -$1.9 billion in Q3 2025.
- Historically, Retained Earnings has averaged -$978.3 million across 5 years, with a median of -$1.7 billion in 2022.
- Annual changes were most pronounced in 2024 — Retained Earnings surged 100.0% — and 2025, when it sank 31949216.67%.
- Heron Therapeutics' Retained Earnings stood at -$19000.0 in 2022, then plunged by 10031552.63% to -$1.9 billion in 2023, then surged by 100.0% to $13000.0 in 2024, then tumbled by 69.23% to $4000.0 in 2025, then tumbled by 250.0% to -$6000.0 in 2026.
- The last three Retained Earnings figures came in at -$6000.0 (Q1 2026), $4000.0 (Q4 2025), and -$1.9 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -838.07 Mn |
| 10 | Heron Therapeutics | 85.57 Mn | 55.60 Mn | 24.07 Mn | -6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | -1.94 Bn |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | -1.92 Bn |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | -1.92 Bn |
| Mar 31, 2024 | -6,000.00 |
| Dec 31, 2023 | -1.91 Bn |
| Sep 30, 2023 | -1.90 Bn |
| Jun 30, 2023 | -1.87 Bn |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | -19,000.00 |
| Sep 30, 2022 | -1.78 Bn |
| Jun 30, 2022 | -1.73 Bn |
| Mar 31, 2022 | -1.68 Bn |
| Dec 31, 2021 | -6,000.00 |
| Sep 30, 2021 | -1.56 Bn |
| Jun 30, 2021 | 41,000.00 |